Get started
PILA PHARMA ABPILA PHARMA ABPILA PHARMA AB

PILA PHARMA AB

No trades
See on Supercharts
Overview
Financials
News Discussions Technicals Seasonals

PILA fundamentals

Key facts

Market capitalization—
Dividend yield (indicated)—
Price to earnings Ratio (TTM)—
Basic EPS (TTM)—
Founded—
Employees (FY)—
CEO—
Website—
About

Pila Pharma AB operates as a clinical stage biotechnology company. It develops pharmaceutical products for the treatment of diabetes. The company was founded by Dorte Xenia Gram in 2014 and is headquartered in Malmo, Sweden.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

PILA does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company